Change of Glycosilated Haemoglobin A1c (HbA1c) From Baseline After 12 Weeks of Treatment Baseline and 12 weeks [clinicaltrials_resource:2928ae2c3d61f630c6a7aceaded52360]
Change of HbA1c from baseline after 12 weeks of treatment.
Note, adjusted means are presented. For the placebo and empa groups, measured values presented are for the model including only these treatment groups, for the metformin group the measured values presented are for the model including only placebo and metformin groups.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change of Glycosilated Haemoglobin A1c (HbA1c) From Baseline After 12 Weeks of Treatment Baseline and 12 weeks [clinicaltrials_resource:2928ae2c3d61f630c6a7aceaded52360]
Change of HbA1c from baseline after 12 weeks of treatment.
Note, adjusted means are presented. For the placebo and empa groups, measured values presented are for the model including only these treatment groups, for the metformin group the measured values presented are for the model including only placebo and metformin groups.
Bio2RDF identifier
2928ae2c3d61f630c6a7aceaded52360
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2928ae2c3d61f630c6a7aceaded52360
measure [clinicaltrials_vocabulary:measure]
Change of Glycosilated Haemoglobin A1c (HbA1c) From Baseline After 12 Weeks of Treatment
time frame [clinicaltrials_vocabulary:time-frame]
Baseline and 12 weeks
description
Change of HbA1c from baseline ...... placebo and metformin groups.
identifier
clinicaltrials_resource:2928ae2c3d61f630c6a7aceaded52360
title
Change of Glycosilated Haemogl ...... reatment Baseline and 12 weeks
@en
type
label
Change of Glycosilated Haemogl ...... 8ae2c3d61f630c6a7aceaded52360]
@en